Supernus Pharmaceuticals, Inc. (SUPN)
NASDAQ: SUPN · Real-Time Price · USD
33.71
+0.04 (0.12%)
Oct 22, 2024, 4:00 PM EDT - Market closed
Supernus Pharmaceuticals Market Cap
Supernus Pharmaceuticals has a market cap or net worth of $1.86 billion as of October 23, 2024. Its market cap has increased by 24.00% in one year.
Market Cap
1.86B
Enterprise Value
1.55B
1-Year Change
24.00%
Ranking
Category
Stock Price
$33.71
Market Cap Chart
Since May 1, 2012, Supernus Pharmaceuticals's market cap has increased from $133.80M to $1.86B, an increase of 1,288.34%. That is a compound annual growth rate of 23.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2024 | 1.86B | 17.35% |
| Dec 29, 2023 | 1.58B | -18.01% |
| Dec 30, 2022 | 1.93B | 24.34% |
| Dec 31, 2021 | 1.55B | 16.99% |
| Dec 31, 2020 | 1.33B | 6.53% |
| Dec 31, 2019 | 1.24B | -28.32% |
| Dec 31, 2018 | 1.74B | -15.02% |
| Dec 29, 2017 | 2.04B | 63.41% |
| Dec 30, 2016 | 1.25B | 90.13% |
| Dec 31, 2015 | 657.50M | 84.54% |
| Dec 31, 2014 | 356.30M | 39.62% |
| Dec 31, 2013 | 255.20M | 45.08% |
| Dec 31, 2012 | 175.90M | 31.46% |
View and export this data all the way back to 2012.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Celldex Therapeutics | 1.91B |
| Mirum Pharmaceuticals | 1.89B |
| Omnicell | 1.89B |
| Patterson Companies | 1.88B |
| Viridian Therapeutics | 1.87B |
| Recursion Pharmaceuticals | 1.86B |
| National HealthCare | 1.84B |
| Belite Bio | 1.84B |